Vascular Disruptive Agents for the Treatment of Cancer /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2010.
|
| Edición: | 1st ed. 2010. |
| Materias: |
Tabla de Contenidos:
- Development of Vascular Disrupting Agents
- Development of Vascular Disrupting Agents
- Pre-Clinical Development
- The Discovery and Characterisation of Tumour Endothelial Markers
- The Use of Animal Models in the Assessment of Tumour Vascular Disrupting Agents (VDAs)
- Combination Therapy with Chemotherapy and VDAs
- Lessons from Animal Imaging in Preclinical Models
- Combining Antiangiogenic Drugs with Vascular Disrupting Agents Rationale and Mechanisms of Action
- Imaging in the Development of Vascular Disruptive Agents
- MRI to Assess Vascular Disruptive Agents
- Contrast Ultrasound in Imaging Tumor Angiogenesis
- Clinical Development
- The Clinical Development of Tubulin Binding Vascular Disrupting Agents
- ASA404 (DMXAA): New Concepts in Tumour Vascular Targeting Therapy
- Vascular Disruptive Agents in Combination with Radiotherapy.